StageZero Life Sciences Ltd.
SZLS
Classement en actions
#36081
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Prix de l'action
$0.02770208
Dernière synchronisation: 2025-03-10
Capitalisation boursière
$2.92M
Changement (1 jour)
-0.46%
Changement (1 an)
443.18%
Pays
CA
Échange StageZero Life Sciences Ltd. (SZLS)
Catégorie
Healthcare
Capitalisation boursière de StageZero Life Sciences Ltd.(SZLS)
Capitalisation boursière: $2.92M
En October 2026, StageZero Life Sciences Ltd. a une capitalisation boursière de $2.92M. Cela fait de StageZero Life Sciences Ltd. la 36081st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de StageZero Life Sciences Ltd. du 2009 au 2026
SZLS par rapport au top 5 des plus populaires stocks
| Prix pour SZLS | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$41,747.22
$123.53K
|
$5.157T | +4,174,721,634.27% | ||
|
$40,231.96
$123.53K
|
$4.970T | +4,023,196,312.35% | ||
|
$33,676.30
$123.53K
|
$4.160T | +3,367,630,256.52% | ||
|
$31,813.14
$123.53K
|
$3.930T | +3,181,313,668.39% | ||
|
$22,870.45
$123.53K
|
$2.825T | +2,287,045,109.78% |
